Free Content Brain Neurotransmitter Deficits in Mice Transgenic for the Huntington's Disease Mutation

Authors: Reynolds, Gavin P.; Dalton, Caroline F.; Tillery, Claire L.; Mangiarini, Laura1; Davies, Stephen W.2; Bates, Gillian P.1

Source: Journal of Neurochemistry, Volume 72, Number 4, April 1999 , pp. 1773-1776(4)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Abstract: Huntington's disease (HD) is associated with an expansion in the CAG repeat sequence of a gene on chromosome 4, resulting in a neurodegenerative process particularly affecting the striatum and with profound but selective changes in content of various neurotransmitters. Recently, transgenic mice expressing a fragment of the human HD gene containing a large CAG expansion have been generated; these mice exhibit a progressive neurological phenotype that includes motor disturbances, as well as neuronal deficits. To investigate their underlying neurotransmitter pathology, we have determined concentrations of GABA, glutamate, and the monoamine neurotransmitters in several brain regions in these mice and control animals at times before and after the emergence of the behavioural phenotype. In contrast to the findings in HD, striatal GABA was unaffected, although a deficit was observed in the cerebellum, consistent with a dysfunction of Purkinje cells. Losses of the monoamine transmitters were observed, some of which are not seen in HD. Thus, 5-hydroxytryptamine and, to a greater extent, 5-hydroxyindoleacetic acid levels were diminished in all brain regions studied, and noradrenaline was particularly affected in the hippocampus. Dopamine was decreased in the striatum in older animals, parallelling evidence for diminished dopaminergic activity in HD.

Keywords: Huntington's disease; Transgenic mice; Catecholamines; 5-Hydroxytryptamine; GABA; Neurodegeneration

Document Type: Research article

DOI: http://dx.doi.org/10.1046/j.1471-4159.1999.721773.x

Affiliations: 1: Division of Medical and Molecular Genetics, GKT Medical and Dental School, Guy's Hospital, London, England 2: Department of Anatomy and Developmental Biology, University College, London, England

Publication date: 1999-04-01

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page